You are here

adalimumab

Amgen prepped to take first slice of AbbVie’s US Humira pie

Amgen prepped to take first slice of AbbVie’s US Humira pie

BioProcess International

Flag link:

180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s Disease

180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s Disease

BioSpace

180 Life Sciencs

Dupuytren's Contracture

Dupuytren's disease

Flag link:

AbbVie's Battle Royale

AbbVie's Battle Royale

TheStreet.com

Flag link:

Phase 3 successful for Amgen's adalimumab biosimilar

Phase 3 successful for Amgen's adalimumab biosimilar

Seeking Alpha

Flag link: